Trials / Completed
CompletedNCT03870490
Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects
An Open-Label Trial to Assess the Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Venatorx Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, open-label study to assess safety and pharmacokinetics of VNRX-5133 and cefepime in the epithelial lining fluid in healthy adult male and female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VNRX-5133 + cefepime | IV infusion (3 doses) |
Timeline
- Start date
- 2019-03-14
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2019-03-12
- Last updated
- 2019-05-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03870490. Inclusion in this directory is not an endorsement.